We are monitoring the impact of COVID-19 on Europe Nuclear Imaging Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1545
Share on
Share on

Europe Nuclear Imaging Market Research Report – Segmented By Diagnostic Technologies, Application, Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) - Industry Size, Share, Trends & Growth Forecast (2020 to 2025)

Pulished: February, 2020
ID: 1545
Pages: 133

Europe Nuclear Imaging Market Size (2020 to 2025)

The size of the Europe Nuclear Imaging Market has been calculated at USD 2.96 billion in 2020 and estimated to be growing at a CAGR of 8.78%, to reach USD 4.51 billion by 2025.

Medical imaging is the method of generating a photographic image of the inside of the body for medical intervention. These devices aid in creating a databank of normal anatomy and physiology of internal organs so that any irregularity can be observed immediately.

Nuclear imaging is most commonly utilized for cardiovascular and oncology applications. It refers to the method of generating visuals of the organs of the body by processing minor quantity of radioactive tracers. The images are obtained using a gamma camera and can be documented on film or on a computer. The growth of the Europe Nuclear Imaging market is mainly due to factors such as an increase in the number of cancer and cardiovascular disease cases, and predilection towards minimally invasive procedures, ready availability of radiopharmaceuticals.

However, factors such as costly procedures & equipment, shortage of supplies, and logistical difficulties are hampering the growth of the market in this region.

This research report on the European Nuclear Imaging Market has been segmented & sub-segmented into the following categories:

By Product: 

  • Standalone PET Nuclear Imaging
  • Standalone SPECT Nuclear Imaging
  • Hybrid Nuclear Imaging

By Application: 

  • Oncology
  • Cardiology
  • Neurology
  • Others

By End-User: 

  • Hospitals
  • Diagnostic Centers
  • Research Centers

By Country: 

  • UK
  • France
  • Spain
  • Germany
  • Italy
  • Russia
  • Sweden
  • Denmark
  • Switzerland
  • Netherlands
  • Turkey
  • Czech Republic
  • Rest of Europe

Regionally, in 2019, Germany accounted for the largest share of the Nuclear Imaging market, followed by France, Italy, and U.K. This market is however projected to witness high growth rate in nascent markets such as Switzerland, Poland, Denmark, and Sweden. Companies are showing a strong interest in enhancing image quality by developing new technologies and creating new devices or novel techniques to achieve images with higher spatial resolution.

Notable companies dominating the Nuclear Imaging market in this region are Mallinckrodt plc, Siemens Medical Solutions, Hitachi Medical Corporation, Medtronic Inc., General Electric Co. (healthcare division), IBA Group, Positron Corporation, Philips Medical Systems, Naviscan, Toshiba Medical Systems Corporation, Carestream Health, Lantheus Medical Imaging Inc., Cardinal Health Inc., and Bayer AG.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Diagnostic Technologies                        

                                5.1.1 Introduction           

                                5.1.2 PET Radioisotopes

                                                5.1.2.1 Rubidium-82

                                                5.1.2.2 Fluorine-18

                                                5.1.2.3 Others

                                5.1.3 SPECT Radioisotopes          

                                                5.1.3.1 Thallium-201

                                                5.1.3.2 Technetium-99m

                                                5.1.3.3 Xenon-133

                                                5.1.3.4 Iodine-123

                                                5.1.3.5 Others

                                5.1.4 Y-o-Y Growth Analysis, By Diagnostic Technologies                

                                5.1.5 Market Attractiveness Analysis, By Diagnostic Technologies              

                                5.1.6 Market Share Analysis, By Diagnostic Technologies               

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 PET             

                                                5.2.2.1 Cardiology

                                                5.2.2.2 Oncology

                                                5.2.2.3 Neurology

                                                5.2.2.4 Others

                                5.2.3 SPECT        

                                                5.2.3.1 Lymphoma

                                                5.2.3.2 Neurology

                                                5.2.3.3 Cardiology

                                                5.2.3.4 Thyroid

                                                5.2.3.5 Others

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application        

                                5.2.6 Market Share Analysis, By Application         

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Diagnostic Technologies

                                                6.1.3.3 By Application

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Diagnostic Technologies

                                                6.1.4.3 By Application

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Diagnostic Technologies

                                                6.1.5.3 By Application

                6.2 U.K                

                6.3 Spain                             

                6.4 Germany                     

                6.5 Italy                               

                6.6 France                          

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Mallinckrodt plc                        

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Siemens Medical Solutions                  

                8.3 Hitachi Medical Corporation               

                8.4 Medtronic Inc.                          

                8.5 General Electric Co. (healthcare division)                       

                8.6 IBA Group                   

                8.7 Positron Corporation                              

                8.8 Philips Medical Systems                        

                8.9 Naviscan                      

                8.10 Toshiba Medical Systems Corporation                          

                8.11 Carestream Health                

                8.12 Lantheus Medical Imaging Inc.                         

                8.13 Cardinal Health Inc.                              

                8.14 Bayer AG                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe Nuclear Imaging Market, By Region, From 2020 to 2025 (USD Billion)
  2. Europe Nuclear Imaging Market, By Diagnostic Technologies, From 2020 to 2025 (USD Billion)
  3. Europe PET Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  4. Europe Nuclear Imaging Market, By PET Radioisotopes, From 2020 to 2025 (USD Billion)
  5. Europe Rubidium-82 Market, By Region, From 2020 to 2025 (USD Billion)
  6. Europe Fluorine-18 Market, By Region, From 2020 to 2025 (USD Billion)
  7. Europe Other PET radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  8. Europe SPECT Radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  9. Europe Nuclear Imaging Market, By SPECT Radioisotopes, From 2020 to 2025 (USD Billion)
  10. Europe Thallium-201 Market, By Region, From 2020 to 2025 (USD Billion)
  11. Europe Technetium-99m Market, By Region, From 2020 to 2025 (USD Billion)
  12. Europe Xenon-133 Market, By Region, From 2020 to 2025 (USD Billion)
  13. Europe Iodine-123 Market, By Region, From 2020 to 2025 (USD Billion)
  14. Europe Other SPECT radioisotopes Market, By Region, From 2020 to 2025 (USD Billion)
  15. Europe Nuclear Imaging Market, By Application, From 2020 to 2025 (USD Billion)
  16. Europe PET Market, By Region, From 2020 to 2025 (USD Billion)
  17. Europe Nuclear Imaging Market, By PET, From 2020 to 2025 (USD Billion)
  18. Europe Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  19. Europe Oncology Market, By Region, From 2020 to 2025 (USD Billion)
  20. Europe Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  21. Europe Other PET applications Market, By Region, From 2020 to 2025 (USD Billion)
  22. Europe SPECT Market, By Region, From 2020 to 2025 (USD Billion)
  23. Europe Nuclear Imaging Market, By SPECT, From 2020 to 2025 (USD Billion)
  24. Europe Lymphoma Market, By Region, From 2020 to 2025 (USD Billion)
  25. Europe Neurology Market, By Region, From 2020 to 2025 (USD Billion)
  26. Europe Cardiology Market, By Region, From 2020 to 2025 (USD Billion)
  27. Europe Thyroid Market, By Region, From 2020 to 2025 (USD Billion)
  28. Europe Other SPECT applications Market, By Region, From 2020 to 2025 (USD Billion)
  29. U.K Nuclear Imaging Market, By Diagnostic Technologies , From 2020 to 2025 (USD Billion)
  30. U.K Nuclear Imaging Market, By PET Radioisotopes, From 2020 to 2025 (USD Billion)
  31. U.K Nuclear Imaging Market, By SPECT Radioisotopes, From 2020 to 2025 (USD Billion)
  32. U.K Nuclear Imaging Market, By Application, From 2020 to 2025 (USD Billion)
  33. U.K Nuclear Imaging Market, By PET, From 2020 to 2025 (USD Billion)
  34. U.K Nuclear Imaging Market, By SPECT, From 2020 to 2025 (USD Billion)
  35. Spain Nuclear Imaging Market, By Diagnostic Technologies , From 2020 to 2025 (USD Billion)
  36. Spain Nuclear Imaging Market, By PET Radioisotopes, From 2020 to 2025 (USD Billion)
  37. Spain Nuclear Imaging Market, By SPECT Radioisotopes, From 2020 to 2025 (USD Billion)
  38. Spain Nuclear Imaging Market, By Application, From 2020 to 2025 (USD Billion)
  39. Spain Nuclear Imaging Market, By PET, From 2020 to 2025 (USD Billion)
  40. Spain Nuclear Imaging Market, By SPECT, From 2020 to 2025 (USD Billion)
  41. Germany Nuclear Imaging Market, By Diagnostic Technologies , From 2020 to 2025 (USD Billion)
  42. Germany Nuclear Imaging Market, By PET Radioisotopes, From 2020 to 2025 (USD Billion)
  43. Germany Nuclear Imaging Market, By SPECT Radioisotopes, From 2020 to 2025 (USD Billion)
  44. Germany Nuclear Imaging Market, By Application, From 2020 to 2025 (USD Billion)
  45. Germany Nuclear Imaging Market, By PET, From 2020 to 2025 (USD Billion)
  46. Germany Nuclear Imaging Market, By SPECT, From 2020 to 2025 (USD Billion)
  47. Italy Nuclear Imaging Market, By Diagnostic Technologies , From 2020 to 2025 (USD Billion)
  48. Italy Nuclear Imaging Market, By PET Radioisotopes, From 2020 to 2025 (USD Billion)
  49. Italy Nuclear Imaging Market, By SPECT Radioisotopes, From 2020 to 2025 (USD Billion)
  50. Italy Nuclear Imaging Market, By Application, From 2020 to 2025 (USD Billion)
  51. Italy Nuclear Imaging Market, By PET, From 2020 to 2025 (USD Billion)
  52. Italy Nuclear Imaging Market, By SPECT, From 2020 to 2025 (USD Billion)
  53. France Nuclear Imaging Market, By Diagnostic Technologies , From 2020 to 2025 (USD Billion)
  54. France Nuclear Imaging Market, By PET Radioisotopes, From 2020 to 2025 (USD Billion)
  55. France Nuclear Imaging Market, By SPECT Radioisotopes, From 2020 to 2025 (USD Billion)
  56. France Nuclear Imaging Market, By Application, From 2020 to 2025 (USD Billion)
  57. France Nuclear Imaging Market, By PET, From 2020 to 2025 (USD Billion)
  58. France Nuclear Imaging Market, By SPECT, From 2020 to 2025 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample